6-methyleneandrost-4-ene-3,17-dione NEW

‌1,2-Dihydro Exemestane | High-Purity Anticancer Intermediate & API Synthesis Reagent‌ 💊🔬

🌟 ‌Product Overview‌

1,2-Dihydro Exemestane is a ‌pharmaceutically active steroid derivative‌ critical for synthesizing anticancer APIs, particularly aromatase inhibitors used in hormone-dependent cancer therapies‌12. As a ‌key intermediate‌, it enables precise enzymatic modifications for oncology drug development, including breast and ovarian cancer treatments‌14. Its structural stability supports large-scale industrial synthesis and R&D applications‌35.

✅ ‌Key Advantages‌

🧪 ‌Applications‌

• ‌Anticancer Drug Synthesis‌

  : Core precursor for ‌exemestane‌ and other aromatase inhibitors‌.

• ‌Pharmaceutical Research‌

  : Reference standard for metabolic pathway studies‌45.

• ‌Industrial Biocatalysis‌

  : Substrate for enzyme-mediated steroid transformations‌13.

• ‌Oncology Formulations‌

  : Supports targeted therapies for hormone-sensitive cancers‌12.

📜 ‌Quality Certifications‌

• ‌GMP-Compliant Production‌

  : ISO 9001-certified facilities‌15.

• ‌Residual Solvents‌

  : <50 ppm (ICH Q3C compliant)‌15.

• ‌Multi-Method Validation‌

  : NMR, FTIR, and LC-MS batch testing‌12.

📈 ‌Market Trends‌

The ‌global oncology intermediates market‌ is projected to grow at ‌7.1% CAGR through 2030‌, fueled by rising demand for precision cancer therapies‌34. Aromatase inhibitors like exemestane dominate ‌22% of the hormone therapy sector‌, underscoring this intermediate’s commercial relevance‌12.